CHAPEL HILL, N.C.--(BUSINESS WIRE)--Aug. 27, 2012--
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to
transforming medicine that transforms lives, announced today that John
R. Plachetka, Pharm.D., the Company’s Chairman, President and Chief
Executive Officer, and Liz Cermak, the Company’s Executive Vice
President and Chief Commercial Officer, will present at the 2012 Stifel
Nicolaus Healthcare Conference on Thursday, September 6, 2012 at 3:15
p.m. (ET), at the Four Seasons Hotel in Boston. The presentation will be
webcast and available for replay on POZEN’s home page at www.pozen.com.
POZEN Inc. is a progressive pharmaceutical company that is transforming
how the healthcare industry addresses unmet medical needs. By utilizing
a unique in-source model and focusing on integrated therapies, POZEN has
successfully developed and obtained FDA approval of two self-invented
products in two years. Funded by these milestone/royalty streams, POZEN
is now creating a portfolio of cost-effective, evidence based integrated
aspirin therapies designed to enable the full power of aspirin by
reducing its GI damage.
POZEN is currently seeking strategic partners to help maximize the
opportunity for its portfolio assets.
The Company's common stock is traded under the symbol “POZN” on The
NASDAQ Global Market. For more detailed company information, including
copies of this and other press releases, please visit www.pozen.com.
Source: POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
Manager, Investor Relations & Public